ÂÜÀòÂÒÂ×

The Scientific and Research Team at Oligomerix is pivotal in advancing the development of novel therapeutics for Alzheimer's disease by focusing on the inhibition of tau self-association. The Lab Manager oversees daily operations and ensures compliance with research protocols, while the Senior Director of Chemistry leads the design and development of small molecule inhibitors. The Scientist, Discovery, conducts experimental research and validates new drug candidates through preclinical studies. This collaborative team drives the company's drug discovery platform towards creating effective therapies for neurodegenerative diseases.